By reducing fat storage, glucagon appears to enhance the weight loss effects of GLP-1
In the connection to inflammation, we showed that elevation of pro-inflammatory cytokine IL-6, increased anxiety at the lightdark test, and smaller hippocampal volume characterized at baseline (before any applied stress) those mice that become susceptible after social defeat stress (SDS) with social withdrawal and impaired transcriptomic-wide changes in ventral dentate gyrus, and that administration of LAC promoted behavioral resilience at the SDS paradigm in this susceptible phenotype [27]
At Meto, we work with patients on both these medications regularly, and the difference between an FDA-approved GLP-1 and an uncharacterized compounded peptide is not minor it is fundamental
Injection site and technique: Subcutaneous absorption rates can vary depending on the injection site (abdomen, thigh, or upper arm) and depth of injection
The 1 mg group lost 8.7% of body weight
Any visible particulate matter disqualifies the medication from use